• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染者接受高效抗逆转录病毒治疗后,CD4 T 细胞计数的重建。

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

机构信息

Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, National Naval Medical Center, Bethesda, Maryland, USA.

出版信息

Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421.

DOI:10.1086/651421
PMID:20218878
Abstract

Sixty-two human immunodeficiency virus (HIV) controllers (6 elite and 56 viremic controllers) in the US Military Department of Defense HIV Natural History Study cohort initiated highly active antiretroviral therapy (HAART) and achieved statistically significant mean CD4 cell count increases, although the gains were lower than those in treated noncontrollers. HIV controllers experienced CD4 cell count reconstitution with HAART regardless of pretherapy viral load, including patients with undetectable viral loads at HAART initiation.

摘要

62 名人类免疫缺陷病毒 (HIV) 控制器(6 名精英控制器和 56 名病毒控制器)在美国国防部 HIV 自然史研究队列中开始接受高效抗逆转录病毒治疗 (HAART),并实现了具有统计学意义的平均 CD4 细胞计数增加,尽管这些增加低于接受治疗的非控制器。HIV 控制器在接受 HAART 治疗后经历了 CD4 细胞计数的重建,无论治疗前的病毒载量如何,包括在 HAART 开始时病毒载量无法检测到的患者。

相似文献

1
CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.HIV 感染者接受高效抗逆转录病毒治疗后,CD4 T 细胞计数的重建。
Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421.
2
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.丙型肝炎病毒(HCV)病毒血症和HCV基因型在一组未接受过抗逆转录病毒治疗的HIV感染个体接受高效抗逆转录病毒治疗后的免疫恢复中的作用。
Clin Infect Dis. 2005 Jun 15;40(12):e101-9. doi: 10.1086/430445. Epub 2005 May 5.
3
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.成功的抗逆转录病毒疗法长期中断对人类免疫缺陷病毒感染患者CD4 + T细胞减少的影响:对间歇性治疗策略的启示。
J Infect Dis. 2002 Sep 15;186(6):851-4. doi: 10.1086/342603. Epub 2002 Aug 28.
4
Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.影响接受长期高效抗逆转录病毒治疗的HIV阳性患者CD4细胞计数增加的因素。
J Infect Dis. 2004 Nov 15;190(10):1860-8. doi: 10.1086/425075. Epub 2004 Oct 8.
5
Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.长期接受高效抗逆转录病毒治疗的人类免疫缺陷病毒感染男性和女性CD4细胞计数轨迹的个体差异:贝叶斯随机变化点模型的应用
Am J Epidemiol. 2005 Oct 15;162(8):787-97. doi: 10.1093/aje/kwi268. Epub 2005 Aug 31.
6
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.高效抗逆转录病毒疗法对曾接受治疗的1型垂直传播HIV感染儿童的长期影响:6年随访
Clin Infect Dis. 2006 Mar 15;42(6):862-9. doi: 10.1086/500412. Epub 2006 Feb 9.
7
CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.CD4 +细胞计数、病毒载量及高效抗逆转录病毒疗法的使用是HIV感染成人身体成分改变的独立预测因素:一项纵向研究。
Clin Infect Dis. 2005 Dec 1;41(11):1662-70. doi: 10.1086/498022. Epub 2005 Oct 19.
8
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.在一个加勒比发展中国家的非临床试验环境中,对高效抗逆转录病毒疗法的免疫和病毒学反应。
HIV Med. 2006 Mar;7(2):99-104. doi: 10.1111/j.1468-1293.2006.00347.x.
9
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.在接受高效抗逆转录病毒治疗并实现持续病毒学抑制的患者中,治疗开始6年后的CD4 +细胞计数。
Clin Infect Dis. 2007 Feb 1;44(3):441-6. doi: 10.1086/510746. Epub 2006 Dec 20.
10
Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.接受高效抗逆转录病毒治疗(HAART)失败的HIV-1感染患者中CD4阳性T细胞计数的不一致变化
Jpn J Infect Dis. 2002 Apr;55(2):62-5.

引用本文的文献

1
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure.针对儿科 HIV 治愈的早期生命免疫治疗的挑战与机遇。
Front Immunol. 2022 Jul 13;13:885272. doi: 10.3389/fimmu.2022.885272. eCollection 2022.
2
Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort.针对HIV病毒控制者的抗逆转录病毒疗法:法国ANRS-CO21 CODEX队列中开始治疗的原因及治疗结果
EClinicalMedicine. 2021 Jun 18;37:100963. doi: 10.1016/j.eclinm.2021.100963. eCollection 2021 Jul.
3
HIV-1 elite controllers: an immunovirological review and clinical perspectives.
HIV-1精英控制者:免疫病毒学综述及临床展望
J Virus Erad. 2019 Sep 18;5(3):163-166. doi: 10.1016/S2055-6640(20)30046-7.
4
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.抗逆转录病毒疗法可降低人类免疫缺陷病毒控制者的 T 细胞活化和免疫耗竭标志物。
Clin Infect Dis. 2020 Apr 10;70(8):1636-1642. doi: 10.1093/cid/ciz442.
5
Harnessing CD8 T Cells Under HIV Antiretroviral Therapy.在 HIV 抗逆转录病毒治疗下利用 CD8 T 细胞。
Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019.
6
Current Treatment Options for HIV Elite Controllers: a Review.HIV精英控制者的当前治疗选择:综述
Curr Treat Options Infect Dis. 2018 Jun;10(2):302-309. doi: 10.1007/s40506-018-0158-8. Epub 2018 Apr 16.
7
Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.精英控制者的长期随访:丙型肝炎病毒合并感染并发症风险更高,与艾滋病病情进展无关。
Medicine (Baltimore). 2017 Jun;96(26):e7348. doi: 10.1097/MD.0000000000007348.
8
Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.巴西北部地区HIV-1病毒血症控制者的免疫学和病毒学特征
BMC Infect Dis. 2017 Jun 1;17(1):381. doi: 10.1186/s12879-017-2491-9.
9
Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.“精英”控制者的临床结局与抗逆转录病毒治疗:文献综述
J Virus Erad. 2015 Apr;1(2):72-77. doi: 10.1016/S2055-6640(20)30488-X.
10
Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.HIV 控制者的免疫和病毒学进展:ANRS CO21 CODEX 研究中病毒“波动”和免疫激活的作用
PLoS One. 2015 Jul 6;10(7):e0131922. doi: 10.1371/journal.pone.0131922. eCollection 2015.